This study will assess the potential effects of calcium carbonate and aluminum/magnesium
hydroxide-containing antacids on the pharmacokinetics (PK) and pharmacodynamics (PD) of
lesinurad in healthy, adult male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Ardea Biosciences, Inc.
Treatments:
Aluminum hydroxide, magnesium hydroxide, drug combination Antacids Lesinurad